Abundance of DNA adducts of methyleugenol, a rodent hepatocarcinogen, in human: Liver samples

Carcinogenesis

Volumn 34, Issue 5, 2013, Pages 1025-1030

  Herrmann, Kristin ^a   Schumacher, Fabian ^a   Engst, Wolfram ^a   Appel, Klaus E ^b   Klein, Kathrin ^c   Zanger, Ulrich M ^c   Glatt, Hansruedi ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^c DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGUANOSINE DERIVATIVE; METHYLEUGENOL; N2 (METHYLISOEUGENOL 3' YL) 2' DEOXYGUANOSINE; N6 (METHYLISOEUGENOL 3' YL) 2' DEOXYGUANOSINE; NUCLEOSIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; CARCINOGEN DNA INTERACTION; CONTROLLED STUDY; DIPLOIDY; EXPERIMENTAL MODEL; EXPOSURE; FEMALE; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; MALE; PRIORITY JOURNAL; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY; TRANS ISOMER; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

CARCINOGENS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA ADDUCTS; EUGENOL; FEMALE; HUMANS; LIVER; MALE; TANDEM MASS SPECTROMETRY;

EID: 84877106342     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt013     Document Type: Article

References (39)

1. European Union (2001) Opinion of the Scientific Committee on Food on Methyleugenol (4-Allyl-1,2-dimethoxybenzene). http://ec.europa.eu/food/fs/sc/scf/out102_en.pdf(last visited on 30 Jan 2013).
2. Miller,E.C. et al. (1983) Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res., 43, 1124-1134.
3. NTP (2000) Toxicology and carcinogenesis studies of methyleugenol. Natl. Toxicol. Program Tech. Report Series, 491, 1-420.
4. 1 mice. Carcinogenesis, 5, 1623-1628.
5. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice. Carcinogenesis, 5, 1613-1622.
6. 32P-postlabeled DNA-aromatic carcinogen adducts. Anal. Biochem., 174, 381-392.
7. Herrmann,K. et al. (2012) Identification of human and murine sulfotransferases able to activate hydroxylated metabolites of methyleugenol to mutagens in Salmonella typhimurium and detection of associated DNA adducts using UPLC-MS/MS methods. Mutagenesis, 27, 453-462.
8. Devereux,T.R. et al. (1999) Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene, 18, 4726-4733.
9. Cartus,A.T. et al. (2012) Metabolism of methyleugenol in liver microsomes and primary hepatocytes: pattern of metabolites, cytotoxicity, and DNA-adduct formation. Toxicol. Sci., 129, 21-34.
10. Schumacher,F. et al. (2013) Optimized enzymatic hydrolysis of DNA for LC-MS/MS analyses of adducts of 1-methoxy-3-indolylmethyl glucosinolate and methyleugenol. Anal. Biochem., 434, 4-11.
11. Nies,A.T. et al. (2009) Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver. Hepatology, 50, 1227-1240.
12. Tretyakova,N. et al. (2012) Quantitation of DNA adducts by stable isotope dilution mass spectrometry. Chem. Res. Toxicol., 25, 2007-2035.
13. Chen,L. et al. (2007) Liquid chromatography-electrospray ionization tandem mass spectrometry analysis of 7-ethylguanine in human liver DNA. Chem. Res. Toxicol., 20, 1498-1502.
14. 2-ethyldeoxyguanosine. Chem. Res. Toxicol., 19, 319-324.
15. Chou,P.H. et al. (2010) Detection of lipid peroxidation-induced DNA adducts caused by 4-oxo-2(E)-nonenal and 4-oxo-2(E)-hexenal in human autopsy tissues. Chem. Res. Toxicol., 23, 1442-1448.
16. Ferlay,J. et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer, 127, 2893-2917.
17. Sherman,M. (2010) Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin. Liver Dis., 30, 3-16.
18. Farazi,P.A. et al. (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer, 6, 674-687.
19. Otteneder,M. et al. (1999) Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts. Mutat. Res., 424, 237-247.
20. Beland,F.A. et al. (1999) Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard. Chem. Res. Toxicol., 12, 68-77.
21. 32P-postlabeling. Chem. Res. Toxicol., 21, 2017-2025.
22. 1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and non-tumorous liver tissue. Carcinogenesis, 12, 2247-2252.
23. 1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma. Hepatology, 16, 1150-1155.
24. 1-DNA adducts formed in vivo. Cancer Res., 48, 6328-6331.
25. 1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report. Gastroenterology, 97, 1281-1287.
26. Chen,S.Y. et al. (2002) Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int. J. Cancer, 99, 14-21.
27. Wang,L.Y. et al. (1998) 4-Aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls. Am. J. Epidemiol., 147, 315-323.
28. Chung,Y.T. et al. (2008) Safrole-DNA adduct in hepatocellular carcinoma associated with betel quid chewing. Toxicol. Lett., 183, 21-27.
29. Lord,G.M. et al. (2004) DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. Am. J. Kidney Dis., 43, e11-e17.
30. 32P-postlabeling analysis. Mutat. Res., 202, 85-91.
31. 32P postlabeling, and immunoprecipitation. Cancer Res., 52, 5307-5312.
32. Ichiba,M. et al. (2003) Expression of 8-hydroxy-2'-deoxyguanosine in chronic liver disease and hepatocellular carcinoma. Liver Int., 23, 338-345.
33. Fujita,N. et al. (2008) Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. J. Viral Hepat., 15, 498-507.
34. Nair,J. et al. (1999) Etheno DNA-base adducts from endogenous reactive species. Mutat. Res., 424, 59-69.
35. 4]guanine, a reagent for the production of internal standards of guanyl DNA adducts. Chem. Res. Toxicol., 8, 333-337.
36. 2,3-ethenoguanine using liquid chromatography/electrospray ionization mass spectrometry. J. Mass Spectrom., 31, 1271-1276.
37. 2-propanodeoxyguanosine adducts as common DNA lesions in rodents and humans. Proc. Natl. Acad. Sci. USA, 91, 7491-7495.
38. Chung,F.L. et al. (2000) Deoxyguanosine adducts of t-4-hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: detection and potential sources. Cancer Res., 60, 1507-1511.
39. Garcea,G. et al. (2006) Oxidative stress in humans following the Pringle manoeuvre. Hepatobiliary Pancreat. Dis. Int., 5, 210-214.